NCT05716451

Brief Summary

This Pilot study will hypothesize that patients with organ insufficiency and breathing assistance in our post-anaesthesia care unit (PACU) and ICU will be mobilized more often to an ICU mobility scale (IMS) ≥ 4 (i.e. standing) using the Liana® mobilizer. Therefore a randomized controlled pilot study will be conducted. The aim is to achieve an important physical function mile stone more often using this device. Secondary hypotheses are:

  1. 1.The intervention will relieve the burden of the health care staff in the unit
  2. 2.The intervention will positively influence the functional outcome of critically ill patients
  3. 3.The intervention is perceived as positive by the patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

April 27, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2025

Completed
Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

January 28, 2023

Last Update Submit

December 12, 2025

Conditions

Keywords

ICUAWMuscle Weakness

Outcome Measures

Primary Outcomes (1)

  • Level of mobilisation (IMS)

    Mean level of mobilisation measured with the Intensive Car Unit Mobility Scale (IMS) till ICU discharge (or Day 28); IMS ranges from 0 (no mobilization) to 10 (independent walking)

    28 Days

Secondary Outcomes (17)

  • Frequency of IMS ≥ 4

    28 Days

  • Handgrip strength

    28 Days

  • MRC Sum Score

    28 Days

  • Diaphragma function

    28 Days

  • CPAx Score

    28 Days

  • +12 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Mobilization incl. support by the Liana. In the intervention group, Liana is used to train trunk stability in a sitting position. If this is successful, the patient is trained to stand. Mobilization to higher levels is performed according to clinical standards.

Device: Device-assisted mobilisation with the sit/stand stabilizer Liana

Control Group

NO INTERVENTION

Standard of Care without the use of the Liana. In the control group the therapy is carried out according to the ward standard without using the Liana.

Interventions

Non-invasive device-assisted mobilisation with LIANA

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intensive care patient with ventilatory support and an expected intensive care stay of at least another 48 h
  • Age ≥ 18 years
  • Current length of intensive care stay \< 48 h

You may not qualify if:

  • Moribund and critically ill
  • Suspected 6-month mortality \> 75%.
  • Increased intracranial pressure
  • Critically ill after cardiopulmonary resuscitation
  • Critically ill with primary neuromuscular disease or motor neuron disease
  • One or more amputated extremities
  • Patients, within 2h after surgery
  • Unstable fractures
  • Severe traumatic brain injury (e.g., brain and skull injuries)
  • Circulatory instability with norepinephrine \> 0.3 µg/kg/min
  • Patients for whom there is an indication for deep sedation (RASS -5)
  • Language barrier
  • Fitting of legs into leg trays is not possible due to e.g. patient weight

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - Univiversitätsmedizin Berlin

Berlin, State of Berlin, 10117, Germany

Location

MeSH Terms

Conditions

Muscle WeaknessCritical Illness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsDisease Attributes

Study Officials

  • Stefan J Schaller, MD

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Clinical Director

Study Record Dates

First Submitted

January 28, 2023

First Posted

February 8, 2023

Study Start

April 27, 2023

Primary Completion

April 4, 2025

Study Completion

November 11, 2025

Last Updated

December 15, 2025

Record last verified: 2025-12

Locations